PREBLICK RYAN (Chief Financial Officer) sold 11.2% of their position (36K shares) of INDIVIOR PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $1.36M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/10/2026ACC: 0002014866-26-000011
Officer· Chief Financial Officer
Since Mar 2026
-36K
Net shares
Net seller
$1.36M
Total sold
1
Open market trades
0B · 1S
1
Total transactions
36K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−36K
Price / share
$37.70
Trade value
$1.36M
% of position
11.2%
6/8/2026
320.75K→284.75K
Total
Net shares
−36K
Net value
-$1.36M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/8/2026 | S · Sale | −36K | $37.70 | $1.36M | 11.2% | 320.75K | 284.75K |
| Total | −36K | -$1.36M | ||||||
Derivative Transactions0
No derivative transactions reported